fda status bpc-157 tb-500 2024 2025 + Blend Peptide Heal, Repair, Recover - BPC-157,
Description
What the Human Trial Record Shows This compound has a documented history in human clinical research that distinguishes it from the vast majority of synthetic research peptides, which have never been tested in human subjects
Peptide therapy uses short chains of amino acids that help signal specific functions in the body
You have an eye disorder called Leber's hereditary optic neuropathy (slow and painless loss of vision)
Research suggests it can promote the reorganization of F-actin in fibroblasts, enhancing their structural integrity and migratory capacity
There seems to be no help out there
